An imaging target TGF- β1 for hepatocellular carcinoma in mice.
CONCLUSION: This pilot study provides an experimental basis for further exploration of the feasibility of TGF-β1 receptor as a target in HCC imaging and in other cancers.
PMID: 28315912 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Nuclear Medicine - Category: Nuclear Medicine Tags: Hell J Nucl Med Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Nanotechnology | Nuclear Medicine | PET Scan | Study | Urology & Nephrology | Victoza